Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.
Vertex Pharmaceuticals Inc. (VRTX) shares rose 4.36% to $468.38 on a strong trading day, breaking a six-day losing streak. The S&P 500 Index and Dow Jones Industrial Average also saw gains of 0.62% and 0.99%, respectively. Despite the rise, VRTX remains 9.87% below its 52-week high of $519.68. Competitors AbbVie Inc. (ABBV), Krystal Biotech Inc. (KRYS), and Arcturus Therapeutics Holdings Inc. (ARCT) also experienced stock increases, but VRTX outperformed them. Trading volume reached 2.1 million, surpassing its 50-day average of 1.4 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments